Ben Feringa – Chair
Ben is a professor at the University of Groningen, the Netherlands. In 2004, he was elected foreign honory member of the American Academy of Arts and Sciences and recently received the Spinoza award, the highest scientific award in The Netherlands, from the Netherlands Organization of Scientific Research. His research has a focus on stereochemistry and his present research interest include organic synthesis, homogeneous (asymmetric) catalysis, molecular switches and motors, self-assembly, nanosystems and new organic materials.
Andrew is professor of biochemical engineering in the Institute for chemical and bioengineering at the Swiss Federal Institute of Technology. His group is actively engaged in the development and application of micro- and nanofluidic systems to chemical and biological problems.
Andrew is the associate director of chemistry at the MRCT Centre for Therapeutics Discovery (CTD) in London, UK. The CTD is the drug discovery arm of the Medical Research Council Technology group, which looks to develop innovative drug screens emerging out of ground breaking MRC research.
Carol is chief executive of the Chemistry Innovation Knowledge Transfer Network (CIKTN) in Runcorn, UK. The initiative aims to improve innovation in UK businesses by increasing their ability to turn chemical science knowledge and expertise into new technology and products.
Chris is science strategy lead for global analytical chemistry at Merck Research Laboratories in Rahway, in the US. He also chairs the organisation within Merck that funds the acquisition and evaluation of new technologies. His research interests centre on the development and application of new separation and analysis technologies to facilitate the discovery and development of pharmaceuticals.
Ian is global research and development (R&D) manager at Agilent Technologies in Wilmington in the US. He is an expert in strategy development, business management, product development & management and portfolio management. He also has interests in analytical science, chemistry and atomic spectroscopy.
Markus is the director at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany. His research interests include synthesis and properties of functional polymers, polymerisation in organised phases and nanodroplets, amphiphilic block copolymers, mesoporous materials and sustainable chemistry.
Mathias is a professor at the University of Liverpool, in the UK. His main research interest concerns self-organisation phenomena on the nanometre size scale. It is quite common in nature on all length scales that both extremely complex, and highly ordered patterns are formed spontaneously from a large number of relatively simple individual parts.
Paul is professor of organic and biological chemistry and head of section at the University of Leicester, in the UK. His areas of research interests cover chemical biology and mechanistic organic chemistry. Each of these areas will involve synthetic chemistry, including experience of spectroscopic methods especially high field nuclear magnetic resonance (NMR), aimed at understanding the mechanism of important chemical and biological reactions.
Philip Ball is a science writer based in London, UK. Formerly an associate editor at Nature, he now writes on all areas of the sciences and on the intersections of science and the wider culture. He also writes The crucible, monthly column in Chemistry World.
Roger studied physical chemistry, becoming the first person to bounce a neutron off a soap bubble, and received a DPhil from the University of Oxford. He was the Science Editor of The Daily Telegraph for two decades and the Editor of New Scientist between 2008 and 2011. Today, he is the Director of External Affairs at the Science Museum Group. Roger has written seven books and had thousands of articles published in newspapers and magazines.
Tom is a professor of chemical biology at the University of Southampton, in the UK. His research interests centre on nucleic acids chemistry, structure, DNA sequence recognition and the applications in biology and medicine. Tom is a fellow of the Royal Society of Edinburgh and of the Royal Society of Chemistry.